LIVE Q1 2026 Earnings EPS of 023 Reported Amid Sparse Disclosure Batam Attracts Growing Interest from Chinese Firms Singapore Remains Leading Investor ANGO Q1 2026 Earnings Strong Profitability Surprise Drives Modest Stock Gain Telomir Pharmaceuticals Q4 2025 Earnings WiderthanExpected Loss as Revenue Remains Absent UGP Q1 2026 Earnings Strong EPS Beat Amid Flat Revenue Ryde Group Q2 2025 Earnings EPS Misses as Company Invests in Growth